Loading tape…Loading tape…
CVS
CVS
CVS
A report indicates that CVS Health's Aetna plans to streamline cancer treatment approvals, highlighting operational developments across its healthcare services. The company carries a market capitalization of approximately $123.43 billion alongside an annual revenue of $402.07 billion. Currently, CVS Health trades with a PE ratio of 25.26, supported by a TTM EPS of 3.84 and a free cash flow yield of 9.53%.
Based on reuters.comWhy CVS Health (CVS) is a Top Value Stock for the Long-Term
CVS Health (CVS) Exceeds Market Returns: Some Facts to Consider
CVS Health collaborates with The Midlife Collective to redefine a woman's midlife health journey
CVS vs. ALHC: Which Medicare Advantage Stock Is the Better Pick Now?
CVS to pay $315 million settlement to resolve DOJ opioid lawsuit
MinuteClinic earns seventh consecutive Joint Commission accreditation, including first evaluation under Medical Center standards
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Blinx with professional market data, charts beside chat, and your portfolio context.
Default quotes are Lang & Schwarz. NASDAQ is the delayed listing price. Charts stay daily. Not investment advice.